Announcement of the Resolution of the 2024 Annual Shareholders' Meeting
release time:
2025-05-14 10:13
AnnouncementNumber: 2025-008
Stock code: 832316 Securities abbreviation: Tian Zheng Biotech Host brokerage: Shenwan Hongyuan underwriting sponsor
Jilin Tianzheng Biotechnology Co., Ltd
Announcement of the Resolution of the 2024 Annual Shareholders' Meeting
I. Meeting Convening and Attendance
(1) Meeting convening situation
The meeting will be held on May 12, 2025
2. Meeting format: √ On-site meeting □ Electronic communication meeting
The venue of the meeting is the conference room on the third floor of the office building, No. 167, Changbai Mountain Street, Hebei Sub-district, Jiaohe City.
3. Voting method of the meeting:
√ On-site voting □ Electronic communication voting
□ Online voting □ Other ways of voting
4. Meeting convener: Board of Directors
5. Chairperson of the meeting: Mr. CAI Tiyuan, Chairman of the Board
6. Explanation of the legality and compliance of the convening situation:
The convening and holding of this shareholders' meeting comply with the provisions of the Company Law, the Securities Law and other relevant laws, administrative regulations, departmental rules, normative documents and the Company's Articles of Association.
(II) Attendance at the meeting
A total of 6 shareholders attended and were authorized to attend this shareholders' meeting, holding a total of 62,040,193 voting shares, accounting for 54.90% of the total voting shares of the company.
(3) The situation of directors, supervisors and senior management personnel of the company attending shareholders' meetings as non-voting participants
The company has 5 current directors and 5 of them are present as observers.
2. There are 3 current supervisors in the company, and 3 are present as non-voting participants.
3. The secretary of the company's board of directors attended the meeting as an observer.
4. Senior management personnel of the company attended the meeting as observers.
Ii. Review of the Motion
(1) Review and approve the "Proposal on the Company's '2024 Board of Directors' Work Report'"
1. Content of the motion:
"2024 Board of Directors' Work Report"
2. Voting result of the motion:
The number of common shares agreed upon was 62,040,193, accounting for 100% of the total number of voting shares present at this meeting. The number of opposing shares is 0, accounting for 0% of the total number of voting shares present at this meeting. The number of abstained shares was 0, accounting for 0% of the total number of voting shares present at this meeting.
3. Abstained from voting
None.
(2) Review and approve the "Proposal on the Company's '2024 Annual Report of the Supervisory Board'"
1. Content of the motion:
"2024 Annual Report of the Supervisory Board"
2. Voting result of the motion:
The number of common shares agreed upon was 62,040,193, accounting for 100% of the total number of voting shares present at this meeting. The number of opposing shares is 0, accounting for 0% of the total number of voting shares present at this meeting. The number of abstained shares was 0, accounting for 0% of the total number of voting shares present at this meeting.
3. Abstained from voting
None.
(3) Review and approve the "Proposal on the Company's '2024 Financial Settlement Report'"
1. Content of the motion:
"2024 Financial Settlement Report"
2. Voting result of the motion:
The number of common shares agreed upon was 62,040,193, accounting for 100% of the total number of voting shares present at this meeting. The number of opposing shares is 0, accounting for 0% of the total number of voting shares present at this meeting. The number of abstained shares was 0, accounting for 0% of the total number of voting shares present at this meeting.
3. Abstained from voting
None.
(4) Review and approve the "Proposal on the Company's '2025 Financial Budget Plan'"
1. Content of the motion:
"Financial Budget Plan for 2025"
2. Voting result of the motion:
The number of common shares agreed upon was 62,040,193, accounting for 100% of the total number of voting shares present at this meeting. The number of opposing shares is 0, accounting for 0% of the total number of voting shares present at this meeting. The number of abstained shares was 0, accounting for 0% of the total number of voting shares present at this meeting.
3. Abstained from voting
None.
(V) Review and approve the "Proposal on the Company's '2024 Annual Report and Abstract of the 2024 Annual Report'"
1. Content of the motion:
"Annual Report 2024 and Summary of the Annual Report 2024"
2. Voting result of the motion:
The number of common shares agreed upon was 62,040,193, accounting for 100% of the total number of voting shares present at this meeting. The number of opposing shares is 0, accounting for 0% of the total number of voting shares present at this meeting. The number of abstained shares was 0, accounting for 0% of the total number of voting shares present at this meeting.
3. Abstained from voting
None.
(6) Review and approve the "Proposal on the Company's '2024 Annual Profit Distribution Plan'"
1. Content of the motion:
In order to enhance the financial stability, strengthen the ability to resist risks, achieve the company's sustained, stable and healthy development, and better safeguard the long-term interests of all shareholders, based on the actual situation of the company, after research and decision by the board of directors: no profit distribution for the year 2024 will be made.
2. Voting result of the motion:
The number of common shares agreed upon was 62,040,193, accounting for 100% of the total number of voting shares present at this meeting. The number of opposing shares is 0, accounting for 0% of the total number of voting shares present at this meeting. The number of abstained shares was 0, accounting for 0% of the total number of voting shares present at this meeting.
3. Abstained from voting
None.
(7) The proposal on re-appointing Zhongxi Certified Public Accountants (Special General Partnership) as the Company's auditing institution for 2025 was deliberated and approved.
1. Content of the motion:
The company intends to continue to employ Zhongxi Certified Public Accountants (Special General Partnership) as the auditing institution for the year 2025, with a term of one year.
2. Voting result of the motion:
The number of common shares agreed upon was 62,040,193, accounting for 100% of the total number of voting shares present at this meeting. The number of opposing shares is 0, accounting for 0% of the total number of voting shares present at this meeting. The number of abstained shares was 0, accounting for 0% of the total number of voting shares present at this meeting.
3. Abstained from voting
None.
Iii. Lawyer's Witnessing Situation
(1) Name of the law firm: Jilin Dahua Mingren Law Firm
(2) Lawyers' names: Li Song, Li Haifeng
(3) Conclusive opinions
The convening and holding procedures of the company's current shareholders' general meeting comply with the provisions of the Company's Articles of Association and relevant laws, administrative regulations, rules and normative documents. The qualifications of the meeting convener, the qualifications of the attendees of this shareholders' general meeting, as well as the voting procedures and results of the meeting are all legal and valid.
Iv. Reference Documents
Resolution of the 2024 Annual General Meeting of Shareholders of Jilin Tianzheng Biotechnology Co., LTD.
Legal Opinion of Jilin Dahua Mingren Law Firm on the 2024 Annual General Meeting of Shareholders of Jilin Tianzheng Biotechnology Co., LTD.
Jilin Tianzheng Biotechnology Co., LTD
Board of Directors
May 12, 2025
next page
next page
Related news
